Clark Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
7,091
+1,160
+20% +$160K 0.08% 94
2026
Q2
$762K Buy
5,931
+121
+2% +$14.2K 0.06% 118
2026
Q1
$699K Buy
5,810
+1,351
+30% +$156K 0.07% 103
2025
Q4
$469K Sell
4,459
-345
-7% -$32.4K 0.05% 128
2025
Q3
$403K Buy
4,804
+2,053
+75% +$169K 0.05% 128
2025
Q2
$218K Buy
+2,751
New +$219K 0.03% 183
2024
Q4
– Sell
-2,195
Closed -$249K – 143
2024
Q3
$249K Buy
+2,195
New +$261K 0.05% 109

Other funds holding MRK

Clark Asset Management's MRK Position: Q3 2026 in Review

Clark Asset Management increased its Merck (MRK) stake by 20% in Q3 2026, buying an estimated $160K and bringing the position to 7,091 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #94.

Clark Asset Management first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Clark Asset Management held 7,091 shares of Merck worth $1.03M as of Q3 2026.
  • Clark Asset Management bought 1,160 Merck shares in Q3 2026, an estimated $160K.
  • Merck made up 0.08% of Clark Asset Management's portfolio in Q3 2026, its #94 holding.
  • Clark Asset Management first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Clark Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.